Odds of faster recovery lifted aerospace and defense "A&D" stocks after the FDA authorized a Coronavirus treatment on Monday. Still, debates around the treatment's effectiveness show that returning to normal is bound to the development of a vaccine.
Low price multiples are luring value-investors who cite solid defense budget and higher air freight demand as reasons to expect a reversal in A&D stocks. Short-term traders are also drawn to the industry as technical analysis tools beep oversold beacons.
While you can find A Ruby Beneath The Rubble, low demand for air travel combined with